黑料网官网

Since our company was founded in 1975, we have devoted ourselves to research to develop new drugs with the belief that nothing is more precious than life and humanity's earnest wish to dream of a world without disease. As a result, in 1990, Nissell Tablet, a new hepatitis treatment drug, was developed for the first time in Korea, creating a new turning point in the field of liver disease treatment. In 1998, a new invention patent for a liver disease treatment drug was obtained and phase 3 clinical trials, which are difficult for pharmaceutical companies to conduct, were conducted. By releasing Fennel, which passed the test, we have firmly established ourselves as an R&D-centered biotechnology company.